BioSyent to Present at Upcoming Investor Conference
August 24 2018 - 12:00PM
BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is
pleased to announce that it will be presenting at the Midwest IDEAS
Investor Conference at The Gwen in Chicago, Illinois. Mr.
René Goehrum, BioSyent’s President and CEO,
will present to investors an overview
of BioSyent’s business and corporate activities
on Wednesday, August 29th at 9:20 a.m. ET. Mr. Goehrum will also be
available for one-on-one meetings during the day on August
29th. Interested investors can request meetings with Mr.
Goehrum through the online conference platform:
https://www.meetmax.com/sched/event_48313/entity_login.html?attendee_role_id=COMPANY.
About BioSyent
Inc.
Listed on the TSX Venture Exchange under the
trading symbol “RX”, BioSyent is a profitable growth-oriented
specialty pharmaceutical company focused on in-licensing or
acquiring innovative pharmaceutical and other healthcare products
that have been successfully developed, are safe and effective, and
have a proven track record of improving the lives of
patients. BioSyent supports the healthcare professionals that
treat these patients by marketing its products through its
community, hospital and international business units.
As of the date of this press release, the
Company has 14,519,603 common shares issued and outstanding.
For a direct market quote for the TSX Venture
Exchange and other Company financial information, please visit
www.tmxmoney.com.
For further information please
contact:
Mr. René C. GoehrumPresident and CEOBioSyent
Inc.Tel: (905) 206-0013E-Mail: investors@biosyent.comWeb:
www.biosyent.com
Biosyent (TSXV:RX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biosyent (TSXV:RX)
Historical Stock Chart
From Apr 2023 to Apr 2024